The effect was investigated of the K + channel blocker, glibenclamide, on the ability of Crotalus durissus cumanensis venom (CDCM) to promote peripheral antinociception. This was measured by formalin-induced nociception in male Swiss mice. CDCM (200 and 300 µg/kg) produced an antinociceptive effect during phase 2 in the formalin test. The effect of CDCM (200 µg/kg) was unaffected by the ATP-sensitive K + channel blocker glibenclamide (2 mg/kg). These results suggest that CDCM is effective against acute pain. However, the ATP-sensitive K + channels pathway is not contributable to the antinociceptive mechanism of CDCM.
Pain is one of the most common reasons for patients to seek medical care. Current analgesics fall into two major classes: non-steroidal anti-inflammatory drugs (NSAIDs) and opioids, both of which have critical liabilities and limitations. Opioids are tightly controlled because of their addictive effects and other serious side effects [1] . Gastrointestinal side effects and effectiveness only in cases of mild to moderate pain limit NSAIDs use [2, 3] . Pain control is an important medical problem. Much research has gone towards the identification of agents that can relieve chronic pain without unwanted side effects. Some snake venoms have demonstrated antinociceptive activity, and certain isolated neurotoxins have demonstrated significant analgesia in animal models. The use of snake venoms as therapeutic agents is almost entirely based on folk medicine and empirical observations. Early in the 1900s, snake venoms were used routinely to control pain associated with advanced cancer [4] .
The analgesic action of Naja snake venom, Crotalus durissus terrificus [5, 6] and C. durissus cascavella has been reported [6, 7] .These studies demonstrated that several elapid and viperid venoms display central and peripheral analgesia, mediated mainly by either opioidergic or cholinergic mechanisms [5, 8, 9, 10] .
Several lines of evidence have suggested that opening of ATP-sensitive K + channels mediates the analgesic action of NO and cGMP. It was demonstrated that the peripheral antinociceptive effect of the nitric oxide donor, sodium nitroprusside involves the opening of ATP-sensitive K+ channels [11] . Furthermore, it was shown that dibutyrylguanosine 3:5′cyclic monophosphate (DbcGMP), a membrane permeable analogue of cyclic GMP, induces peripheral antinociception through specific opening of ATPsensitive K + channels [12] . Recent investigations have shown that nociceptor desensitization induced by various drugs capable of stimulating the arginine-NO-cGMP pathway, such as morphine, ketorolac and diclofenac, is mediated by activation of ATP-sensitive K + channels [13, 14, 15] . Taken together, these data NPC Natural Product Communications 2010 Vol. 5 No. 7 1103 -1106 suggest a link between the activation of the NO-cGMP pathway and the opening of ATP-sensitive K + channels.
We have previously reported that Crotalus durissus sp. snake venom (CDV) activates the NO-cGMP pathway in the periphery and, in order to further characterize the cascade of molecular events involved in the antinociceptive effect of the crotalid venom, the present work was undertaken to determine the role of peripheral K + ATP channels on this effect. For this purpose, we tested the action of specific and nonspecific blockers of K + ATP channels on the antinociceptive effect of venom.
Experimental data have indicated that neurotoxins isolated from Elapid venoms induce antinociception when evaluated in phasic and tonic rodent pain models. In our present study CDCM at 200 and 300 μg/kg markedly lowered the pain score of the second phase in the formalin test although it had no effect on the first phase. The formalin test in mice is a useful test for evaluating mild analgesics [16] . Compared with other frequently used tests for analgesia, in this model, the pain stimulus is continuous and may thus bear strong similarity with some kinds of pain encountered in the clinical setting. The test has two different phases which reflect different types of pain: the first phase seems to be due to direct stimulation of nociceptors, while the second phase may be due to the production and release of inflammatory mediators [16, 17] .
Crotoxin, the main neurotoxic component of the South American rattlesnake, induces an antinociceptive effect in experimental models of acute pain [18] . In this study, crotoxin did not cause an antinociceptive effect in the formalin test (data not shown). The reason for this discrepancy is not apparent. However, differences in the experimental model used for pain evaluation and/or in the doses and route of administration of crotoxin could contribute to these results [19] .
The advantage of the formalin model of nociception is that it can discriminate pain in its central and/or peripheral components. It has been reported that formalin-induced persistent pain in mice paws produced a distinct biphasic nociception [20, 21] . Central analgesics, such as narcotics, inhibit both phases, while peripherally acting drugs, such as steroids (hydrocortisone, dexamethasone) and NSAIDs suppress mainly the late phase [20, 22] .
It was evidenced that the antinociceptive effect of C. durissus terrificus venom on hyperalgesia involves the activation of peripheral ATP-sensitive K + channels, since glybenclamide, a blocker of these K + channels antagonizes the venom effect [23] . To verify a possible mechanism by which CDCM produces antinociception, we have examined the effect of glibenclamide, a blocker of K + ATP channels. The antinociception produced by CDCM was found to be glibenclamide-insensitive. To confirm that opening of peripheral ATP-sensitive K + channels is able to induce antinociception, diazoxide, a specific opener of these channels was used. The results demonstrate that activation of these K + channels increases the pain threshold and antagonizes hyperalgesia.
Sensitivity to sulfonylurea is commonly used to characterize ATP-sensitive K + channels [24] . Our results demonstrated that the sulfonylurea glibenclamide could not prevent the peripheral antinociceptive effect induced by CDCM, suggesting that these channels are not tonically activated by CDCM. In conclusion, the study demonstrates the antinociceptive activity of Crotalus durissus cumanensis venom in the test model of chemical nociception induced by formalin, which merits further studies regarding the precise site and mechanism of action. [25] .
Measurement of antinociceptive activity:
Antinociception was assessed using the formalin test. Groups of mice were treated as above with either CDCM (50 -200 μg/kg, i.p.) or vehicle (10 mL/kg, i.p.) and 30 min later, each mouse was given 20 μL of 1% formalin (in 0.9% saline, subplantar) into the right hind paw. The duration of paw licking (s) as an index of painful response was determined at 0-5 min (early phase, neurogenic) and 20-25 min (late phase, inflammatory) after formalin injection. In order to verify the possible mechanism of CDCM antinociception (200 μg/kg), the animal group pretreated with glibenclamide (2 mg/kg, i.p.) was used. Glibenclamide were administered 15 min before the CDCM. To confirm that opening of peripheral ATPsensitive K + channels is able to induce antinociception, diazoxide (3 mg/kg, i.p.) was used as a positive control.
Statistical analysis:
The results were expressed as mean ± SEM. Statistical significance was analyzed by the one-way analysis of variance (ANOVA) followed by Student-Newman-Keul´s test. Values were considered statistically significant at p < 0.05.
